GTG Reaches Settlement with One Lambda | GenomeWeb

NEW YORK (GenomeWeb News) – Genetic Technologies today announced it has executed a Covenant Not to Sue and Release agreement with transplant diagnostics firm One Lambda.

The terms of the agreement were not disclosed, and Genetic Technologies did not elaborate on the nature of its dispute with One Lambda, based in Canoga Park, Calif. Last week, the Australian firm, which has sued numerous firms claiming infringement of its non-coding DNA technology, announced four such lawsuits.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: variant linked to obesity risk in Samoans, health of cloned animals, and more.

Researchers explore using genome editing to treat inherited eye diseases, New Scientist reports.

Olympic athletes this summer will also undergo gene doping testing, according to Wired.

A study finds that the lower funding rate seen among women of color is more due to race than gender, according to BuzzFeed News.